GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for uracil phosphoribosyltransferase (Q2P2V7)

Analyse AlphaFold monomer V2.0 prediction for uracil phosphoribosyltransferase (Q2P2V7) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q2P2V7
Type
protein
Length
210 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x084C9507B8890B44F4aE79C08a93A4457A564360
Molecule
Uracil phosphoribosyltransferase
UniProt
Q2P2V7
Pockets
1 · best druggability 0.73

Structure

1 distinct chain · 34% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUracil phosphoribosyltransferaseprotein21034% helix, 34% strandQ2P2V7

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13250.730.8536empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.